SSGJ-608 is a humanized monoclonal antibody targeting IL-17A. SSGJ-608 can be used in the research of autoimmune and inflammatory diseases, such as moderate-to-severe plaque psoriasis[1].
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
